Understanding Fluoroquinolone Resistance in Campylobacter jejuni
Author Information
Author(s): Han Jing Sahin, Orhan Barton, Yi-Wen Zhang, Qijing Zhang
Primary Institution: Iowa State University
Hypothesis
What mechanisms contribute to the development of fluoroquinolone resistance in Campylobacter jejuni?
Conclusion
The study found that the Mfd protein plays a crucial role in promoting fluoroquinolone resistance in Campylobacter jejuni by increasing mutation rates.
Supporting Evidence
- Ciprofloxacin treatment increased the expression of the mfd gene, which is linked to mutation frequency.
- Mutation of the mfd gene led to a significant reduction in the emergence of fluoroquinolone-resistant mutants.
- Overexpression of mfd resulted in a tenfold increase in the frequency of spontaneous fluoroquinolone-resistant mutants.
Takeaway
Campylobacter bacteria can become resistant to antibiotics, and a specific protein helps them mutate faster, making it harder to treat infections.
Methodology
The researchers used DNA microarray analysis to compare gene expression in Campylobacter jejuni treated with ciprofloxacin and conducted experiments to assess mutation rates.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully replicate human infection scenarios.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website